Seeing Is Believing
Currently out of the existing stock ratings of Adam Walsh, 62 are a BUY (89.86%), 7 are a HOLD (10.14%).
Analyst Adam Walsh works with a stock forecast success ratio of 65.33% fulfilled within 213.47 days on average. Previously, Adam Walsh worked at STIFEL.
Adam Walsh’s has documented 135 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GLPG, Galapagos NV ADR at 10-Jul-2020.
Analyst best performing recommendations are on VRTX (VERTEX PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) at 7/18/2017. The price target of $154 was fulfilled within 1 day with a profit of $21.84 (16.53%) receiving and performance score of 165.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
17
1 years 3 months 5 days ago
0/1 (0%)
$10.12 (147.09%)
Buy
25
1 years 3 months 6 days ago
0/6 (0%)
$18.01 (257.65%)
Buy
17
$8.63 (103.11%)
17
1 years 11 months 2 days ago
1/6 (16.67%)
$12.9 (314.63%)
115
Buy
15
2 years 5 months 13 days ago
0/1 (0%)
$7.49 (99.73%)
Buy
9
$0.63 (7.53%)
13
2 years 6 months 20 days ago
3/10 (30%)
$6.03 (203.03%)
392
What Year was the first public recommendation made by Adam Walsh?